Y-90 Radioembolization
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Y-90 Radioembolization, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Y-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of Unresectable and Locally-Advanced Hepatocellular Carcinoma [Phase 2]